Aronora Secures Investment From New York Blood Center
Aronora CEO Dr. Erik Tucker elected Fellow of the National Academy of Inventors (NAI)
Voice of Industry: How Aronora is Developing ‘Paradigm-Shifting Therapies’
Aronora Announces Clinical Data to Be Presented at the 63rd American Society of Hematology Annual Meeting
Aronora Reports Positive Topline Data From Phase 2 Study of AB023 in Hemodialysis Patients
Experimental Drug Aims to Prevent Blood Clots Without Boosting Risk of Bleeding
Aronora Has Big Plans for Its Cardiovascular Drugs
Aronora Announces Clinical Data to be Presented at the 62nd American Society of Hematology Annual Meeting
Portland Biotech Aronora Inks $9m+ Deal with XOMA for Drug Royalties
XOMA Acquires Royalty Rights to Five Hematology Candidates
Aronora’s New Blood Clot Treatment Receives FDA Fast Track Designation
Portland Biotech Startup May Have the Remedy for Blood Clots
40 Under 40 2015: Erik Tucker, Aronora
Bayer HealthCare and Aronora Establish Partnership for the Pre-Clinical Manufacturing of AB-022
Cool Spaces: Marrying First Rate Research Labs with a Killer View
Bayer HealthCare Starts Special Lab Space-Model CoLaborator for Promising Life Sciences Companies
